Latest News

Subscribe to our latest news feedFeed

22.05.2013|Symbiotics shows its support for sustainable investments and sponsors the Geneva Sustainable Investment Forum (GFSI) & Zurich Sustainable Investment Forum (ZFSI)

Symbiotics is sponsoring two upcoming Sustainable Investment Forums in Switzerland on June 7th at the Swissôtel Métropole in Geneva and June 13th at Hotel Widder in Zurich.

Read More

21.05.2013|Michel Guillet elected to the Board of Directors

Symbiotics is pleased to announce that Michel Guillet was elected to their Board of Directors at their annual general assembly in late April. Mr. Guillet has held several top management roles in the industrial and investments sectors and more recently in the area of private equity.

Read More

22.04.2013|New book published on Small Enterprise Impact Investing

A second investor’s guide published by Symbiotics on emerging and frontier markets explores the “missing middle” beyond microfinance by reviewing the various forms of small enterprise financing intermediaries. This book was written as an introductory research guide to small enterprise impact investing, with the objective of defining this new investment theme and mapping its universe. It offers information for investors and other people who are interested in this space and helps to provide further transparency and understanding of this topic.

Read More

22.04.2013|New Emerging Market Sustainable Finance index, actively used by fund managers

Symbiotics has upgraded its “SMX – Listed MFI” index with a new “SMX – Emerging Sustainable Finance” index”, a change motivated by fund managers and clients actively using it for some of their portfolios. The index has indeed outperformed both global and emerging market indexes, which has triggered this further interest.

Read More

16.04.2013|Press Release: Symbiotics becomes regulated by Swiss Financial Markets Supervisory Authority (FINMA)

Symbiotics is pleased to announce that the company has been granted a license as an asset manager of collective investment schemes by FINMA, the Swiss Financial Market Supervisory Authority. The process of transformation into a regulated entity has allowed Symbiotics to benchmark itself against best practices in the asset management industry, in key areas such as governance, internal control, risk management and compliance and to strengthen the company’s processes and organization where required.

Read More

28.03.2013|Webinar on Latin American Impact Investing

In the context of its Small Enterprise Impact Investing initiative with the City of London Corporation and Oxfam GB, Symbiotics has decided to put a special emphasis on Latin America. Its first step in this project has been to launch a survey among members of Forum Empresa, the CSR association for the region. InnovacionAL, a boutique consulting firm, has been mandated to conduct the study, in partnership with Codespa and IADB/MIF. In parallel to this, an introductory webinar took place March 27th, which included 70 participants.

Read More

26.02.2013|A closer look at the microfinance market in the Philippines

The Philippines’ microfinance sector continues to be highly fragmented although if it is looked at it purely from the perspective of financial inclusion, we can see that a lot of progress has been made. On one hand, you can find the rural banks run by wealthy families and catering mostly to the salaried part of the population. On the other hand, you have a network of NGOs catering to the lower income population group. One can also find many small cooperatives scattered across the rural areas. In addition to these players, private lending companies and individual moneylenders also proliferate.

Read More

14.02.2013|Symbiotics syndicates a USD 10 million loan to Colombian MFI Fundación de la Mujer

In January 2013, Symbiotics syndicated a loan offering for Fundación de la Mujer Bucaramanga, an MFI based in Northeastern Colombia. The transaction was made through four microfinance funds that Symbiotics has been advising and managing for several years. Symbiotics’ solid track record in both fund management and investment analysis and its nearly 10-year presence in Latin America have played an important role in the MFI’s choice to move ahead with this funding.

Read More

15.01.2013|Symbiotics experiences record high origination in second half of 2012

Since last summer, after strong efforts to reinforce its market outreach, Symbiotics experienced several very strong months of loan disbursement to its microfinance institution clientele. During the second semester, the company disbursed over USD 200 million with two months around USD 40m and a peak at USD 84 million in November. The loans were disbursed to MFIs in 22 countries and through 11 different investment vehicles/funds.

Read More

15.01.2013|Growing interest in local currency strategies, portfolios outperforming in 2012

This year the microfinance local currency fund managed by Absolute Portfolio Management (APM) in Vienna has grown to USD 40 million and reached 8.8% of net yield in USD terms, making it the best performing microfinance fixed income fund in the industry. The portfolio has diversified its outreach through 18 currencies and 37 investments. The success of this strategy has been followed by many and now serves as a new benchmark for investors.

Read More

12345

 

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree